M
Maxime Dougados
Researcher at University of Paris
Publications - 1144
Citations - 78022
Maxime Dougados is an academic researcher from University of Paris. The author has contributed to research in topics: Rheumatoid arthritis & Ankylosing spondylitis. The author has an hindex of 134, co-authored 1054 publications receiving 69979 citations. Previous affiliations of Maxime Dougados include French Institute of Health and Medical Research & Paris Descartes University.
Papers
More filters
Journal ArticleDOI
Rémission dans la polyarthrite rhumatoïde précoce sous traitements des fonds conventionnels. Résultats à deux ans de suivi de la cohorte marocaine El Ayachi
Karima Benbouazza,Hanan Rkain,B. Benchekroun,Bouchra Amine,Fatiha Bzami,Leila Benbrahim,O. Atouf,M. Essakalli,Redouane Abouqal,Maxime Dougados,Najia Hajjaj-Hassouni +10 more
TL;DR: Dans cette cohorte de patients atteints de PR precoce et traites par DMARDs conventionnels, notamment par le MTX en monotherapie, the remission a deux ans de suivi a ete obtenue chez un tiers des patients.
Journal ArticleDOI
Clusterin, a potential pathophysiological actor in rheumatoid arthritis
Performances of the ASAS Axial Spondyloarthritis Criteria for Diagnosis and Classification Purposes in Patients Visiting a Rheumatologist Because of Chronic Back Pain : The Declic Study.
Anna Molto,Simon Paternotte,D. Comet,C. Hacquard-Bouder,Martin Rudwaleit,Pascal Claudepierre,van der Heijde, , D.,Maxime Dougados +7 more
Journal ArticleDOI
Long-term Tolerability and Efficacy of Golimumab in Active Non-Radiographic Axial Spondyloarthritis: Results From Open-Label Extension.
Désirée van der Heijde,Maxime Dougados,Walter P. Maksymowych,G. Bergman,Sean P. Curtis,A. Tzontcheva,Susan Huyck,George Philip,Joachim Sieper +8 more
TL;DR: The GO-AHEAD study as mentioned in this paper evaluated the long-term efficacy and safety of golimumab (GLM) in patients with non-radiographic axial spondyloarthritis (nr-axSpA).